News

  • All
  • Cardiovascular
  • Central Nervous System
  • Gastroenterology
  • Syncrosome News
Day-8 before The 4TH Neuroscience R&D Technologies Conference

Emmanuelle Bettendorf, Account Manager, and Sandra Robert, Scientific Manager will participate next week to the 4th edition of the Neuroscience R&D technologies in Munich, 4th-5th October. Our Scientific Manager, Sandra Robelet, will launch a talk on the new preclinical strategy combining in vitro and in vivo models...

Chateau Lacoste hosts the annual seminar of Syncrosome

Last month, all the Syncrosome team participated to our annual seminar. Different meetings were organized with a very good participation of everyone on: Satisfactory points and also what need to be improved in 2018 to maintain or improve 90% of customer satisfaction. Next in vivo scientific challenges...

Syncrosome recrute un Directeur d’Etudes précliniques – Metabolic disease.

DESCRIPTION DU POSTE : SYNCROSOME est une société de recherche préclinique, spécialisée dans la mise au point de modèles de pathologie afin de proposer aux industriels de tester l'efficacité de leurs candidats médicaments dans différentes indications.Nous travaillons en étroite collaboration avec les scientifiques des groupes pharmaceutiques et...

Syncrosome keeps increasing its skills in the Cardiovascular area

In the framework of our development, we are proud to announce our political will to strengthen our capabilities for cardiovascular studies by the recruitment of our new scientific colleague, Guillaume Bourdier. He will be in charge, with the scientific and technical team, of managing cardiovascular studies...

Syncrosome and the Microbiome … Follow us at Pharmabiotics2018

Syncrosome invites you to visit us at Pharmabiotics2018, March 14th to November 15th 2018, in Paris, France. This Conference dedicated to the Microbiome will keep Syncrosome's team up to date in this new area of development! Emmanuelle Bettendorf, our Business Developer would be delighted to meet you...